BlinkLab Ltd Requests Trading Halt for Autism Screening Announcement
Key points
- BlinkLab Ltd requests trading halt for upcoming announcement on national autism screening program
- Trading halt to remain in place until earlier of announcement release or market open on March 23
- Autism screening program is material to the company
Full summary
BlinkLab Ltd, an ASX-listed company, has requested a trading halt on its securities (ASX: BB1) pending the release of an announcement regarding the launch of a country-wide national autism screening program. The company has stated that the autism screening program is material to BlinkLab. The trading halt will remain in place until the earlier of the announcement's release or the commencement of normal trading on Monday, 23 March 2026. BlinkLab has confirmed that it is not aware of any reason why the trading halt should not be granted and that it is not aware of any other information necessary to inform the market about the trading halt.
Summary generated by a large language model. Please interpret with care.